Literature DB >> 6253812

Lignans in man and in animal species.

K D Setchell, A M Lawson, F L Mitchell, H Adlercreutz, D N Kirk, M Axelson.   

Abstract

In our laboratories, for several years, two phenolic compounds have been detected during gas chromatographic-mass spectrometric analysis of urinary steroid extracts from human and animal species. Although features of the mass spectra of their trimethylsilyl (TMS) ether derivatives resembled those of oestrogens, they were atypical of steroids. The possibility that they were artefacts of the isolation procedures was discounted after careful studies with blanks, by varying the extraction method and because they were present almost exclusively as conjugates of glucuronic acid. Several of the general characteristics of the unknown compounds were reported after one (referred to as compound 180/442) was found to have a cyclic pattern of excretion during the menstrual cycle of an adult vervet monkey (Fig. 1). An investigation of the nature and distribution of the compounds has shown them to be urinary constituents in humans, baboons, vervet monkeys and rats, and further related compounds have been detected, so far only in vervet monkey urine. We now report spectroscopic and chemical studies that show the two original compounds to be lignans, which have a 2,3-dibenzylbutane skeleton as their basic structure. Unlike all previously known natural lignans, invariably of plant origin, the two mammalian compounds carry phenolic hydroxy groups only in the meta position of the aromatic rings.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253812     DOI: 10.1038/287740a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

2.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

3.  Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.

Authors:  D D Kitts; Y V Yuan; A N Wijewickreme; L U Thompson
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

4.  The dietary origin of the urinary lignan HPMF.

Authors:  A Coert; C A Vonk Noordegraaf; M B Groen; J van der Vies
Journal:  Experientia       Date:  1982-08-15

5.  The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine.

Authors:  M Axelson; D N Kirk; R D Farrant; G Cooley; A M Lawson; K D Setchell
Journal:  Biochem J       Date:  1982-02-01       Impact factor: 3.857

Review 6.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Purification of a new peroxidase catalysing the formation of lignan-type compounds.

Authors:  I Frías; J M Siverio; C González; J M Trujillo; J A Pérez
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

8.  Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria.

Authors:  Cheng-Zhi Wang; Xiao-Qing Ma; Dong-Hui Yang; Zhi-Rong Guo; Gui-Rong Liu; Ge-Xin Zhao; Jie Tang; Ya-Nan Zhang; Miao Ma; Shao-Qing Cai; Bao-Shan Ku; Shu-Lin Liu
Journal:  BMC Microbiol       Date:  2010-04-16       Impact factor: 3.605

9.  Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.

Authors:  Kenneth D R Setchell; Nadine M Brown; Linda Zimmer-Nechemias; Brian Wolfe; Pinky Jha; James E Heubi
Journal:  Food Funct       Date:  2014-03       Impact factor: 5.396

10.  Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol.

Authors:  W V Welshons; C S Murphy; R Koch; G Calaf; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.